Elimusertib

Elimusertib (Bay 1895344) is an experimental anticancer drug which acts as an inhibitor of ataxia telangiectasia and Rad3 related protein.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Elimusertib (Bay 1895344) is an experimental anticancer drug which acts as an inhibitor of ataxia telangiectasia and Rad3 related protein. This is involved in DNA repair following damage, and so inhibiting this protein causes cancer cells to become more vulnerable to other chemotherapy drugs. Elimusertib is in early stage clinical trials against advanced solid tumors.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1330274976 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.